Similar Papers

Paper Title
Journal
Date
Author
An open-label study to assess the safety and efficacy of naporafenib (ERAS-254) administered with trametinib in previously treated patients with locally advanced unresectable or metastatic solid tumor malignancies with RAS Q61X mutations (SEACRAFT-1).
Alexander I Spira ... Joyce Antal
Journal of Clinical Oncology | VOL. 42
Alexander I Spira, et. al.Alexander I Spira ... Joyce Antal
01 Jun 2024
Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D mutations.
Anthony W Tolcher ... Pasi A Janne
Journal of Clinical Oncology | VOL. 41
Anthony W Tolcher, et. al.Anthony W Tolcher ... Pasi A Janne
01 Feb 2023
Phase 1 study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in patients with advanced solid tumors or lymphoma.
Jiajian Liu
Journal of Clinical Oncology | VOL. 41
Jiajian LiuJiajian Liu
01 Jun 2023
Abstract 5707: Preclinical evaluation of KRLS-017, a potent, highly selective and reversible CDK7 inhibitor with broad antitumor effect in preclinical models, in preparation for a Phase 1 clinical trial in advanced solid tumor malignancies
Alison L Hannah ... Shigeyuki Kono
Cancer Research | VOL. 84
Alison L Hannah, et. al.Alison L Hannah ... Shigeyuki Kono
22 Mar 2024
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Cancer-Specific Utility Instrument for Health Economic Evaluations: A Synopsis of the EORTC QLU-C10D User Manual and Current Validity Evidence
Simone Seyringer ... Eva M Gamper
European Journal of Cancer | VOL. -
Simone Seyringer, et. al.Simone Seyringer ... Eva M Gamper
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama ... Salvatore Provenzano
European Journal of Cancer | VOL. -
Annalisa Trama, et. al.Annalisa Trama ... Salvatore Provenzano
01 Jan 2025
Neoadjuvant or perioperative immunotherapy for resectable melanoma: the need for biomarkers
Eva Ellebæk ... Inge Marie Svane
European Journal of Cancer | VOL. -
Eva Ellebæk, et. al.Eva Ellebæk ... Inge Marie Svane
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.